- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT02139865
The Effects of Lifting Light or Heavy Weights on Muscle Growth and Strength in Trained Young Men
The Effects of Resistance Training Intensity on Muscular Hypertrophy and Strength in Young, Resistance Trained Men
When practicing weightlifting regularly the body makes new proteins within the muscle.
These new proteins can increase the size of the cells within the muscle to make them larger, a process called hypertrophy. The common convention surrounding gains in skeletal muscle size and strength is that heavy weights are needed. In contrast, lifting lighter weights are thought to be required to induce muscular endurance and not to promote growth. However, it has previously been shown in untrained men that lifting lighter weights results in similar gains in muscle mass and strength as lifting heavier weights. The purpose of this study is to examine how performing resistance training of different intensities (light or heavy weights) affects the degree of muscle growth and strength gain in individuals who are already resistance training.
This information will be valuable when designing exercise protocols for increasing muscle size and strength at all ages, or in individuals returning from injury, as a way to stimulate muscle growth and promote strength gains without the need to lift heavy weights.
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
Patients will visit the laboratory of Dr. Stuart Phillips at the Ivor Wynne Centre (IWC) at McMaster University for 14 weeks for a number of tests and exercise sessions.
Each visit will be as follows:
Visit 1:
Upon obtaining consent, eligible participants will complete a medical screening questionnaire to determine their readiness to perform exercise as well as a filling out a form to determine subject characteristics. Participants will begin collecting data for their first 3-day diet record. They will record their diet (2 weekdays and a weekend day) again at 6 weeks (mid-protocol) and at 12 weeks of the study.
Visit 2:
Participants will report the lab between 08.00 and 10.00 h to undergo body composition scans including BodPod (to assess fat mass), bioelectrical impedance (BIA - to assess your total body water content), and Dual-energy x-ray- Absorptiometry (DXA- to determine bone mineral content). All tests will be performed in the post-absorptive state (12 hours). Participants will also have a familiarization with the lab and exercise equipment to determine preliminary resistance training (RT) loads.
Visit 4:
Participants will report to the lab to determine their one-repetition-maximum on the leg press, leg extension, bench press and shoulder press. This will be done by having participants attempt a weight based on their familiarization session; if they can complete this weight though a full range of motion with good form, they will rest 3-5 min and then attempt a higher weight until their 1RM is reached.
Visit 5:
Participants will report to the lab in the post-absorptive state (12 hours) for a resting muscle biopsy from the muscle on the outside of their thigh.
Visits 6: Participants will be randomly assigned to one of two exercise intensity treatment groups: ~30% of 1RM (which equates to ~20-25 repetitions per set) for 3 sets to failure (25 subjects) or 80% of 1RM for 3 sets to failure (another 25 subjects). All sets will have 60 seconds of rest in between. On two occasions (one at the beginning of the study another at the end), participants will return to the lab in the post-absorptive state and a catheter (plastic tube with a small needle) will be inserted into a vein in your arm. A resting blood sample will be taken. Upon completion of their first exercise session, subsequent blood samples will be taken at 15 minutes, 30 minutes 60 minutes to determines an acute time course of the changes in blood metabolites and hormones.
Visit 7-54:
Participants will attend supervised exercise sessions 4 times per week (Monday, Tuesday, Thursday and Friday) alternating lower body and upper body focused sessions for 12 weeks. Participants in the 30% (LOW) group will perform approximately 20-25 repetitions per set while participants in the 80% (HIGH) group will perform approximately 8-12 repetitions per set. Immediately following each resistance training session as well as prior to sleep, participants will consume 30g of whey protein. 1RM testing will be repeated every three weeks throughout the protocol and will be conducted prior to beginning the last of every 12 training sessions. Prior to completing their final training session (session number 48) participants will again arrive to the lab in the post-absorptive state for blood sampling procedure as described previously.
Visit 55:
Participants will arrive in the post absorptive (fasted) state 48 hours following their last training session. They will undergo a final BodPod, DEXA and BIA scan to determine body composition as well as a final resting biopsy of the vastus lateralis muscle.
Study Type
Enrollment (Actual)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
Ontario
-
Hamilton, Ontario, Canada, L8S 4L8
- McMaster University
-
Hamilton, Ontario, Canada, L8S 4K1
- Exercise Metabolism Research Laboratory, McMaster Univeristy
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- Male
- Aged 18-30 years old
- Non-obese (Body mass index less than 30 kg/m2)
- Non-smoker
- Healthy based on questionnaire responses (see exclusion criteria)
- Resistance trained (Resistance training > 2 times per week for 2 years, minimum 1 lower body exercise session per week)
Exclusion Criteria:
- Allergies to milk proteins (whey or casein)
- Any acute or chronic illness, cardiac, pulmonary, liver, or kidney abnormalities, uncontrolled hypertension, insulin- or non-insulin dependent diabetes or other metabolic disorders-all ascertained through medical history screening questionnaires
- Arthritic conditions
- Individuals who consume any analgesic or anti-inflammatory drug(s), prescription or non- prescription, chronically will be excluded
- A history of neuromuscular problems
- Individuals on any medications known to affect protein metabolism (i.e. corticosteroids, non-steroidal anti-inflammatories, or prescription strength acne medications).
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Other
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Experimental: 30%
Training at 30% 1RM
|
Participant exercises using a protocol tailored at 30% of their 1RM
|
Experimental: 80%
Training at 80% 1RM
|
Participant exercises using a protocol tailored at 80% of their 1RM
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Muscle Volume
Time Frame: 0 weeks (baseline) and 12 weeks
|
Change from baseline at 12 weeks Measured via 4 compartment model
|
0 weeks (baseline) and 12 weeks
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Gene expression
Time Frame: 0 weeks (baseline) and 12 weeks
|
Change from baseline at 12 weeks .
Gene expression for proteins involved in muscle protein synthesis measured from muscle biopsy.
|
0 weeks (baseline) and 12 weeks
|
Collaborators and Investigators
Sponsor
Investigators
- Principal Investigator: Stuart Phillips, Ph.D., McMaster University
Publications and helpful links
Study record dates
Study Major Dates
Study Start
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Estimate)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- REB 14-333
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Muscle Weakness
-
St. Luke's-Roosevelt Hospital CenterCompletedFall Risk | Quadriceps Muscle Weakness | Adductor Muscle WeaknessUnited States
-
Association Pro-arteActive, not recruitingWeakness, Muscle | AmyotrophiaFrance
-
University of Central ArkansasCompletedPelvic Floor Muscle WeaknessUnited States
-
Ludwig Boltzmann Institute of Electrical Stimulation...Medical University of Vienna; European Union; Comenius University; Ministry of...CompletedMuscle Weakness Condition | Therapy EffectAustria, Slovakia
-
Rutgers, The State University of New JerseyRecruitingPhysical Disability | Muscle Atrophy or Weakness | Muscle Loss | Physical Inactivity | Delirium in Old Age | Hospital Acquired Condition | Weakness, MuscleUnited States
-
University of Central FloridaCompletedMuscle Weakness | Muscle Atrophy | Muscle Loss | Weakness, Muscle | Injury, KneeUnited States
-
University of MilanCompleted
-
University of Texas Southwestern Medical CenterTerminatedMuscle Cramp | Statin Adverse Reaction | Weakness, Muscle | AcheUnited States
-
Damanhour UniversityCompletedNeuromuscular Electrical Stimulation | ICU Acquired Muscle WeaknessEgypt
-
Messiah CollegeNot yet recruiting
Clinical Trials on 30% 1RM
-
Université de Technologie de CompiegneUniversity of Copenhagen; Centre Hospitalier Compiègne-NoyonUnknownAging | Exercise Training | Skeletal Muscle | Connective TissueFrance
-
Universiti Putra MalaysiaRecruiting
-
Unilever R&DCompletedVascular Diseases | HypercholesterolemiaGermany
-
Reproductive Endocrinology Associates of CharlotteCompletedAneuploidy | Mitochondrial DNAUnited States
-
Mayo ClinicCompleted
-
Hospital Israelita Albert EinsteinFundação de Amparo à Pesquisa do Estado de São PauloCompletedFrail Elderly SyndromeBrazil
-
Chang Gung Memorial HospitalCompleted
-
National Yang Ming UniversityCompletedTranscranial Magnetic Stimulation | Non-specific Chronic Neck Pain | Neuromuscular Control | Office WorkersTaiwan
-
University of Texas at AustinCompleted
-
Rush University Medical CenterWithdrawnChronic Low-back Pain | Peripheral Neuropathy | CRPS